Indian Pharma Market - December 2015 Highlights : steady double digit growth continues

IPM clocked 8349 Crs in December 2015 and grew at 11.9%

1. Among the top 10, Mankind grew by 18.1%, Alkem by 18.0% & Lupin at 15.0%
2. In the top 50, Hetero has the highest growth of 33.3% followed by Wockhardt at 29.7% & Bharat Serums at 27.8%
3. In the 11-20 ranked Alembic has the highest growth of 24.0% followed by Micro* at 20.4% & Intas at 20.2%
4. In the 21-30 ranked, Wockhardt has the highest growth at 29.7% followed by Cadila at 22.2% & FDC at 16.8%
5. In the 31-40 ranked, Hetero grew at 33.3% followed by Bharat Serums at 27.8% and AstraZeneca at 14.5%
6. In the 41-50 ranked, Troikaa has the highest growth at 16.8% followed by Wallace* at 15.4% & Win-Medicare at 11.2%
7.  In the 51-60 ranked, Boehringer grew at 60.6% followed by Corona at 39.8% & Centaur at 30.6%
8. In the 61-70 ranked, Fresenius Kabi grew at 27.0% followed by RPG grew at 23.9% and East India at 19.7%
9. In the 71-80 ranked, Samarth grew at 35.3% followed by Walter Bushnell at 21.5% and Roche at 20.1%
10. In the 81 -90 ranked, Galpha grew at 41.2% followed by Med Manor grew at 35.6% followed by Jagsonpal at 17.9%
11. In the 91- 100 ranked, Ozone grew at 47.0% followed by Veritaz at 29.5% and Dey’s Medical at 28.0%
12. 100th Biggest Corporate is Gland Pharma and 150th Biggest Corporate is Claris in the IPM
13. Mercury enters the Top 150 corporate as on MAT Dec 2015

Indian Vs. MNC

1. Indian companies have grown at 13.4% versus 7.1% for MNCs in December 2015
2. In the top 50 in MNCs, AstraZeneca by 14.5% followed by MSD* at 11.5% & Janssen at 8.8%
3. Under the Non-NLEM category Indian Companies grew at 14.5% whereas MNCs grew at 6.8%

NLEM, Non NLEM & Non-Scheduled Para 19 Market:

 NLEM containing molecules market grew at 7.5% whereas the non DPCO market grew by 12.7% & Non-Sch Para 19 Market at 2.9% resulting in an overall growth of 11.9% for December 2015

NLEM & Non - NLEM Category showed unit growth at 4.7% and 3.8% respectively. The Non-Sch Para 19 Market grew at 2.9% from unit perspective

10 therapy areas have outgrown the IPM growth

1.  Respiratory Market grew at 18.1%, Gastrointestinal market grew at 13.2% , Pain & Analgesics market grew at 11.3% whereas Anti-infectives grew at 14.4%
2.  Anti-diabetic market grew at 15.1% & Cardiac at 9.4% in Chronic Business
3.  Derma market grew by 11.4% & Urology Market at 12.7%
4.  Cardiac Market crosses 12k Crs and the difference between Cardiac and GI Market now stands at 746 Crs

Regional Dynamics:

1. From regional perspective 15 regions have outgrown the IPM growth
2.  Bihar market grew the highest at 25.0%% followed by Punjab market at 22.0% & Jharkhand Market at 21.1%
3.  Tamil Nadu market grew at 8.1% & 2 regions had negative growth in December 2015

Molecules:

1. Amoxycillin + Clavulanic Acid market grew at 16.4% & Glimepiride + Metformin Market grew at 10.9%

1. Paracetamol grew at 37.4%
2. Atorvastatin 3.7%
3. Probiotic Microbes at 22.9%
4. Cefixime 10.8%, Pantoprazole 13.2%
5. Montelukast + Levocetrizine at 13.9%
6. Glimepiride + Metformin + Pioglitazone at 14.5%
7. Vitamin-D at 20.2%
8. Hydroquinone + Mometasone + Tretinoin at -9.1%
9. Voglibose + Metformin + Glimepiride at 30.9%
10. Rosuvastatin at 16.2%
11. Protein Supplements at 5.2%
12. Azithromycin at 19.4%
13. Calcium Carbonate + Vit D3 market at -1.8%
14. Paracetamol + Phenylephrine + Chlorpheniramine at 16.3%

Brands:

1. Mixtard leads the pack with 34 Crs followed by Corex at 30 Crs, Glycomet GP & Augmentin at 28 Crs

1. Few Brands who have gained ranks include Meronem (+94), Unwanted Kit (+56), Rotarix (+52), Trajenta (+35), Spasmoproxyvon Plus, Januvia (+27), Betnovate C (+26), Vertin (+23), Azithral (+22), Panderm Plus (+21), Rantac, Telma H (+19), Ultracet, Gluconorm G, Jalra M (+18), Mucain (+17), Ascoril Plus (+16), Calpol, Budecort, Betnesol (+15), Orofer XT, Betnovate N (+14), Telma, Zifi, Rosuvas, Levipil (+13), Dolo (+12), Pan D, Eltroxin (+11), Galvusmet (+10), Pantop, Allegra (+9), Jalra (+5), Sinarest (+4) In top 100 Brands over December -14

1. Few Brands that have moved up ranks fastest into Top 300 Brands for the month of December - 15 are Havrix, Ocid, Anafortan, Vaxigrip, Grafeel

1. 300th Biggest Brand is Bio D3 Plus from Macleods.

New Launches in IPM:

1. Total 234 Brands & 396 SKUs launched in December 2015

1. Top New Brands for December -15 are Dacihep, Loftair, Vilamid & Osmopres

1. Two Teneligliptin Brands launched in Dec-15 - Tenlimac & Teneza

1. Within the VMS category we see Ultra CO-Q (Meyer), Nervijen NP (Jenburkt), BD & D3 (Delvin), Theloxin C (Sundyota) & Gemshell (Mankind)

1. Within Anti-diabetic we see Riax & Riaxm XR launch in Saxagliptin market from DRL

1. Within Respiratory we see Albutamol Plus (Centaur), Macbery DX (Macleods), Derisal (Zydus), Viscodyne LS Plus (Wockhardt), Lesafe (Saffron)

1. Three launches seen in Carica Papaya Market – Caripap, Minmin PB & Platimax

1. Ledihep is the biggest launch in Sofosbuvir + Ledipasvir Market & Dacihep in Daclatasvir Market

1. Biggest New Launch by an MNC is Lobun in December 2015

Data Source: AIOCD Pharmasofttech AWACS